These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2945089)

  • 41. Solid and solution state conformation of 1L-1-O-acetyl-2,3:5,6-di-O-isopropylidene-chiro-inositol.
    Sureshan KM; Miyasou T; Watanabe Y
    Carbohydr Res; 2004 Jul; 339(10):1803-7. PubMed ID: 15220090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 7,8-Dihydroxy-4-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolinium bromide monohydrate, a dopamine agonist.
    Hempel A; Ma LY; Camerman A; Mastropaolo D; Camerman N
    Acta Crystallogr C; 2005 Dec; 61(Pt 12):o681-2. PubMed ID: 16330847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist.
    Collin S; Evrard G; Vercauteren DP; Durant F; Carrupt PA; van de Waterbeemd H; Testa B
    J Med Chem; 1989 Jan; 32(1):38-42. PubMed ID: 2521253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.
    Hall H; Ogren SO; Florvall L
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):211-5. PubMed ID: 6542298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of 5-substituted 5-hydroxy-2-pyrrolidones, metabolites of the antipsychotic benzamide remoxipride.
    Gawell L; Hagberg CE; Högberg T; Widman M
    Acta Chem Scand (Cph); 1989 May; 43(5):476-80. PubMed ID: 2577294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular modeling and crystallographic studies of 4-amino-N-phenylbenzamide anticonvulsants.
    Duke NE; Codding PW
    J Med Chem; 1992 May; 35(10):1806-12. PubMed ID: 1588559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships of new muscarinergic dibenzodioxazocines.
    Kálmán A; Párkányi L; Valkó K; Mátrai G; Batke J; Gaál J
    Acta Biochim Biophys Hung; 1989; 24(1-2):143-58. PubMed ID: 2514535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theoretical conformational studies on some dopamine antagonistic benzamide drugs: 3-pyrrolidyl- and 4-piperidyl derivatives.
    van de Waterbeemd H; Testa B
    J Med Chem; 1983 Feb; 26(2):203-7. PubMed ID: 6827536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preferred conformations of serotonin in relation to receptor sites.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):433-42. PubMed ID: 1135509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatial requirements of the Na channel binding site for class I antiarrhythmics as derived from the crystal structures of 4-substituted 2,6-bis(1-pyrrolidinylmethyl)phenols.
    Główka ML; Dargie RL; Codding PW
    J Med Chem; 1991 Sep; 34(9):2678-84. PubMed ID: 1654426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides.
    Nilsson J; Homan EJ; Smilde AK; Grol CJ; Wikström H
    J Comput Aided Mol Des; 1998 Jan; 12(1):81-93. PubMed ID: 9570091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformation and interactions of dopamine hydrochloride in solution.
    Callear SK; Johnston A; McLain SE; Imberti S
    J Chem Phys; 2015 Jan; 142(1):014502. PubMed ID: 25573567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding.
    Dahl SG; Hough E; Hals PA
    Biochem Pharmacol; 1986 Apr; 35(8):1263-9. PubMed ID: 2870716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamide drug models.
    Clark CR; Garcia-Roura LE
    J Chromatogr Sci; 1989 Mar; 27(3):111-7. PubMed ID: 2708496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural studies on the two forms of 8-bromo-2',3'-O-isopropylideneadenosine.
    Fujii S; Fujiwara T; Tomita K
    Nucleic Acids Res; 1976 Aug; 3(8):1985-96. PubMed ID: 967683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformations of antipyrines.
    Roumanos M; Kertesz M
    J Phys Chem A; 2011 May; 115(18):4832-9. PubMed ID: 21491880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of solvation on the ionization and conformation of raclopride and other antidopaminergic 6-methoxysalicylamides: insight into the pharmacophore.
    Tsai RS; Carrupt PA; Testa B; Gaillard P; el Tayar N; Högberg T
    J Med Chem; 1993 Jan; 36(2):196-204. PubMed ID: 8423592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetamines.
    Horn AS; Post ML; Kennard O; Di Sanserverino R
    J Pharm Pharmacol; 1975 Jan; 27(1):13-7. PubMed ID: 235609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QSAR on substituted salicylamides.
    Norinder U; Högberg T
    Prog Clin Biol Res; 1989; 291():369-72. PubMed ID: 2726875
    [No Abstract]   [Full Text] [Related]  

  • 60. A theoretical conformational study of substituted O-anisamides as models of a class of dopamine antagonists.
    Pannatier A; Anker L; Testa B; Carrupt PA
    J Pharm Pharmacol; 1981 Mar; 33(3):145-9. PubMed ID: 6116754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.